S'abonner

Cardiac Function and Functional Capacity in Patients With Long COVID: A Comparison to Propensity-Matched Community Controls - 02/01/25

Doi : 10.1016/j.echo.2024.09.006 
Thomas H. Marwick, MBBS, PhD, MPH a, b, c, d, e, , Noah Wexler, MBBS a, c, Joel Smith, MSc a, Leah Wright, PhD a, c, Felicia Ho, MBBS a, c, Marc Oreto, BSc a, c, Ashleigh-Georgia Sherriff, BSc a, c, Richard Allwood, BSc a, Yusuke Sata, MD, PhD a, Stefano Manca, PhD a, Erin Howden, PhD a, b, Quan Huynh, PhD a, b
a Imaging Research Lab, Baker Heart and Diabetes Institute, Hobart, Tasmania, Australia 
b Baker Department of Cardiometabolic Health, University of Melbourne, Melbourne, Victoria, Australia 
c Department of Cardiology, Western Health, Melbourne, Victoria, Australia 
d Department of Cardiology, Royal Hobart Hospital, Hobart, Tasmania, Australia 
e Cardiovascular Health Flagship, Menzies Institute for Medical Research, Hobart, Tasmania, Australia 

Reprint requests: Thomas H. Marwick, MBBS, PhD, MPH, Baker Heart and Diabetes Institute, Melbourne, PO Box 6492, Melbourne, Victoria 3004, Australia.Baker Heart and Diabetes InstituteMelbournePO Box 6492MelbourneVictoria3004Australia

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Abstract

Background

Cardiac impairment has been associated with acute COVID-19 since the earliest reports of the pandemic. However, its role in postacute sequelae of COVID-19 (“long COVID”) is undefined, and many existing observations about cardiovascular involvement in postacute sequelae of COVID-19 are uncontrolled.

Objective

To compare the prevalence of cardiac dysfunction in patients with long COVID and noninfected controls from the same community and explore their association with functional capacity.

Methods

Echocardiography was used to assess cardiac structure and function, including the measurement of global longitudinal strain (GLS), in 190 participants with long COVID. All underwent assessment of functional impairment by subjective (Duke Activity Status Index) and objective tests (6-minute walk test). The 190 participants from the long COVID group were matched with those from 979 patients who underwent the same tests in the pre-COVID-19 era, using a propensity score.

Results

The 190 patients with long COVID had similar age and risk factor profiles to those of their matched controls. Left ventricular dimensions and geometry, but not diastolic parameters, were significantly altered in the long COVID group. The long COVID group had subclinical systolic dysfunction (GLS 18.5% ± 2.6% vs 19.3% ± 2.7%, P = .005), and more long COVID patients had abnormal (<16%) GLS (13% vs 8%, P = .035). The association of long COVID with abnormal GLS (odds ratio, 1.49 [1.04, 2.45]) was independent of—and had a similar or greater effect size than—age and risk factors. There was no interaction of long COVID with the association of risk factors with GLS. As expected, the long COVID group had significant subjective (<85% predicted METS; 72% vs 5%, P < .001) and objective functional impairment (29% vs 24%, P = .026), but GLS was only weakly associated with both subjective (r = 0.30, P = .005) and objective (r = 0.21, P = .05) functional impairment. The presence of long COVID was independently associated with subjective (odds ratio = 159.7 [95% CI, 61.6-414.2]) and objective functional impairment (odds ratio = 2.8 [95% CI, 1.5-5.2]).

Conclusions

Impaired GLS and left ventricular dimensions are the echocardiographic features that are overrepresented in long COVID, and this association is similar to and independent of other risk factors. Impaired GLS is weakly associated with functional impairment.

Le texte complet de cet article est disponible en PDF.

Central Illustration

This comparison in cardiac function and functional capacity in patients with long COVID to propensity-matched community controls shows that although diastolic markers were not different, LV strain (although many values were still within the normal range) was significantly worse than in control subjects. However, there was only a weak association of cardiac function with functional capacity.



Central Illustration : 

This comparison in cardiac function and functional capacity in patients with long COVID to propensity-matched community controls shows that although diastolic markers were not different, LV strain (although many values were still within the normal range) was significantly worse than in control subjects. However, there was only a weak association of cardiac function with functional capacity.


Central IllustrationThis comparison in cardiac function and functional capacity in patients with long COVID to propensity-matched community controls shows that although diastolic markers were not different, LV strain (although many values were still within the normal range) was significantly worse than in control subjects. However, there was only a weak association of cardiac function with functional capacity.

Le texte complet de cet article est disponible en PDF.

Highlights

A study of echo and functional assessment of 212 people post-COVID was performed.
The patients were matched to 979 patients tested in the pre-COVID era.
More post-COVID patients had subclinical LV dysfunction (12% vs 7%, P = .04).
Association of COVID with abnormal GLS was independent of age, sex, and risk factors.
GLS was weakly associated with both subjective and objective functional impairment.

Le texte complet de cet article est disponible en PDF.

Keywords : COVID-19, Post-acute sequelae of COVID-19, Long COVID, Myocardial dysfunction, Echocardiography and global longitudinal strain

Abbreviations : 2D, 6MWD, BMI, CMR, DASI, GLS, LV, METS, RV


Plan


 This study was supported in part by the National Heart Foundation, Canberra (105282) and the National Health and Medical Research Council, Canberra (2005874), Australia.


© 2024  American Society of Echocardiography. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 38 - N° 1

P. 16 - janvier 2025 Retour au numéro
Article précédent Article précédent
  • Mitral Annular Disjunction: An Approximation to the Truth
  • Hector I. Michelena, Joseph J. Maleszewski, Jeremy D. Collins
| Article suivant Article suivant
  • Reduction of Coronary Flow Velocity Reserve as the Main Driver of Prognostically Beneficial Coronary Revascularization
  • Lauro Cortigiani, Nicola Gaibazzi, Quirino Ciampi, Fausto Rigo, Domenico Tuttolomondo, Francesco Bovenzi, Dario Gregori, Scipione Carerj, Mauro Pepi, Patricia A. Pellikka, Eugenio Picano, Stress Echo 2030 study group

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.